ALMR - Alamar Biosciences, Inc.

22
22.000   100.000%

Share volume: 4,888,469
Last Updated: 04-17-2026
Measuring And Control Equipment/Lab Analytical Instruments: 0.30%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$22.00
P/E Ratio 
N/A
DAY RANGE
$21.50 - $24.50
EPS 
N/A
52 WEEK RANGE
$21.50 - $24.50
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$4,888,469
AVERAGE 30 VOLUME 
$4,888,469
Company detail
CEO: Yuling Luo
Region: US
Website: alamarbio.com
Employees: 222
IPO year: 2026
Issue type:
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Our mission is to power precision proteomics to enable the earliest detection of disease. We are a commercial-stage proteomics company establishing a gold standard in protein detection and analysis. Our principal executive offices are located in Fremont, California.

Recent news